NEU 3.16% $13.18 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,016 Posts.
    lightbulb Created with Sketch. 781
    zedcorp: "....gut feeling NEU will be approved in Feb 2023."

    zedcorp/others: Yes, indeed, let's hope for approval by the FDA already during February.... (possible dates I have in mind: 13.2./14.2./20.2./21.2. - all purely for personal reasons and wild guesses...)

    wasa
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.